Low Efficiency of the Moloney Murine Leukemia Virus Reverse Transcriptase during Reverse Transcription of Rare t(8;21) Fusion Gene Transcripts
Open accessThe DOI matches its Crossref record.
Abstract
The resolving power of RT-PCR is limited by the efficiency of RNA-to-cDNA conversion. Methods to determine this efficiency, using a real-time PCR assay for quantifying AML1-MTG 8 [t(8;21)] fusion gene transcripts, are described. The efficiency is shown to be directly proportional to RNA template levels. The Moloney murine leukemia virus (MMLV) reverse transcriptase enzyme's conversion efficiency was calculated to be approximately 20%. The efficiency was even lower (6%) when target templates were rare (single molecules) in the RT reactions. Levels of nonspecific or background RNA present in the RT reaction reduced the reverse transcriptase's conversion efficiency. This background effect was particularly pronounced when the specific template was present in rare amounts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Quantitative real-time RT-PCR – a perspective
Bustin, S. A., Benes, V, Nolan, T., & Pfaffl, M. W. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01755 · Cited by 1,321
“It is significantly lower when target templates are rare (Karrer et al. 1995) and is negatively a ff ected by non-specific or background nucleic acid present in the RT reaction (Curry et al. 2002, Stahlberg et al. 2004 b ).”
Backgroundvan der Velden, V. H. J., Hochhaus, A., Cazzaniga, G., Szczepanski, T., Gabert, J., & van Dongen, J. J. M. (2003) · Leukemia · doi:10.1038/sj.leu.2402922 · Cited by 563
Comparison of Reverse Transcriptases in Gene Expression Analysis
Ståhlberg, A., Kubista, M., & Pfaffl, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.035469 · Cited by 240
Galang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311887200 · Cited by 132
Metadata
- Authors
- Curry, J., McHale, C., & Smith, M. T.
- Venue
- BioTechniques
- Publisher
- Informa UK Limited
- Published
- 2002-04
- Volume
- 32
- Issue
- 4
- Pages
- 768-775
- ISSN
- 0736-6205 (ISSN-L)
- 1940-9818
- OpenAlex
- W2301020843
- Cited by
- 43
- References
- 0
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.